Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases
dc.creator | Mouliou D.S. | en |
dc.date.accessioned | 2023-01-31T09:01:45Z | |
dc.date.available | 2023-01-31T09:01:45Z | |
dc.date.issued | 2022 | |
dc.identifier | 10.1080/14787210.2022.2089653 | |
dc.identifier.issn | 14787210 | |
dc.identifier.uri | http://hdl.handle.net/11615/76780 | |
dc.description.abstract | Introduction: Emerging infectious diseases’ diagnosis has been a major problem in most hospitals and other senior care facilities, especially for the current Coronavirus Disease 2019 (COVID-19). The various clinical manifestations, and the several radiology and laboratory data combined with the misleading test results for identifying the virus, are responsible for certain misdiagnoses, especially for suspected cases that visit the emergency department and require urgent management and further treatment. Areas Covered: The major challenges for emerging infectious diseases’ molecular diagnosis are being described here on a great scale, and, finally, strategies for a precise and on-the-spot molecular diagnosis are thoroughly discussed. Related literature was searched using the PubMed, Science Direct, and EMBASE databases published until May 2022 on the general information for viral infections and relevant false test results. Expert Opinion: Emerging diseases’ molecular diagnosis via current common diagnostic assays seems to be extremely tricky, and front-line physicians and other senior care facilities should be able to recognize some falsely diagnosed cases or even prevent their existence. Further biotechnologic revolution concerning viral molecular diagnostics will be evident in the near future, thus new methods’ limitations should be highlighted to physicians from the very beginning of their performances and wide utilization. © 2022 Informa UK Limited, trading as Taylor & Francis Group. | en |
dc.language.iso | en | en |
dc.source | Expert Review of Anti-Infective Therapy | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132394439&doi=10.1080%2f14787210.2022.2089653&partnerID=40&md5=2012989b97fd3eee02eef14b51466332 | |
dc.subject | antibody detection | en |
dc.subject | biotechnology | en |
dc.subject | diagnostic error | en |
dc.subject | emergency ward | en |
dc.subject | enzyme linked immunosorbent assay | en |
dc.subject | health care facility | en |
dc.subject | health care utilization | en |
dc.subject | human | en |
dc.subject | molecular diagnosis | en |
dc.subject | molecular dynamics | en |
dc.subject | nonhuman | en |
dc.subject | Review | en |
dc.subject | virus infection | en |
dc.subject | communicable disease | en |
dc.subject | hospital emergency service | en |
dc.subject | molecular pathology | en |
dc.subject | Communicable Diseases, Emerging | en |
dc.subject | COVID-19 | en |
dc.subject | COVID-19 Testing | en |
dc.subject | Emergency Service, Hospital | en |
dc.subject | Humans | en |
dc.subject | Pathology, Molecular | en |
dc.subject | Taylor and Francis Ltd. | en |
dc.title | Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases | en |
dc.type | other | en |
Αρχεία σε αυτό το τεκμήριο
Αρχεία | Μέγεθος | Τύπος | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο. |